Back to Search Start Over

Acquisition rate of antibody to hepatitis B surface antigen among medical and dental students in Japan after three-dose hepatitis B vaccination

Authors :
Keiko Katayama
Junko Tanaka
Ko Ko
Masayuki Ohisa
Channarena Chuon
Shintaro Nagashima
Chikako Yamamoto
Masaharu Yoshihara
Aya Sugiyama
Tomoyuki Akita
Source :
Vaccine. 37:145-151
Publication Year :
2019
Publisher :
Elsevier BV, 2019.

Abstract

Background Health care workers (HCWs) are at high risk of contracting blood-borne infections including hepatitis B virus (HBV) infection. In Japan, all HCWs are required to receive HB vaccination before beginning work. This study aimed to investigate the dynamics of the HB surface antibody (anti-HBs) titer after a three-dose HB vaccination in HCWs and to determine effective scheduling of HB vaccination for non-responders. Methods Subjects included 832 medical and dental students who had received a three-dose HB vaccination (Bimmugen® 0.5 ml/vial). Anti-HBs was measured three times (before the third dose and 1 and 5 months after the third dose) using the CLIA method. The cut-off value of anti-HBs acquisition was 10 mIU/mL. After booster doses (three maximum) were administered to non-responders, the anti-HBs titers were measured again. Results Out of 832 students, 491 were analyzed, of which 58.9% (289) were male. Anti-HBs-positive rates before the third dose and 1 and 5 months later were 47.9%, 95.9%, and 89.0%, respectively. The relationship between the antibody titer at one month (x) and 5 months (y) was estimated by log10y = log10x − 0.134 (P Conclusion Anti-HBs titer decreases by an average of 20% within 4 months between the 1st and 5th month after the third dose. Therefore, anti-HBs titer should be measured periodically after completing the three-dose vaccination. Additionally, results suggested that booster doses are effective if administered with the same schedule as primary vaccination.

Details

ISSN :
0264410X
Volume :
37
Database :
OpenAIRE
Journal :
Vaccine
Accession number :
edsair.doi.dedup.....1bdb2e292e39f8338928d9322d321416
Full Text :
https://doi.org/10.1016/j.vaccine.2018.11.019